Influenza virus polymerase uses a capped primer, derived by 'cap-snatching' from host pre-messenger RNA, to transcribe its RNA genome into mRNA and a stuttering mechanism to generate the poly(A) tail. By contrast, genome replication is unprimed and generates exact full-length copies of the template. Here we use crystal structures of bat influenza A and human influenza B polymerases (FluA and FluB), bound to the viral RNA promoter, to give mechanistic insight into these distinct processes. In the FluA structure, a loop analogous to the priming loop of flavivirus polymerases suggests that influenza could initiate unprimed template replication by a similar mechanism. Comparing the FluA and FluB structures suggests that cap-snatching involves in situ rotation of the PB2 cap-binding domain to direct the capped primer first towards the endonuclease and then into the polymerase active site. The polymerase probably undergoes considerable conformational changes to convert the observed pre-initiation state into the active initiation and elongation states.

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature14009DOI Listing

Publication Analysis

Top Keywords

capped primer
8
flua flub
8
influenza
5
structural insight
4
insight cap-snatching
4
rna
4
cap-snatching rna
4
rna synthesis
4
synthesis influenza
4
polymerase
4

Similar Publications

Green nanomaterials are increasingly used to improve plant growth and phytochemical traits. This study employed Eucalyptus globulus leaf extract, a medicinal plant, as a bio-reductant and capping agent to synthesize copper oxide nanoparticles (CuO-NPs), which were applied as seed primers for Lactuca sativa (lettuce), an annual species prized for its short germination time and rich bioactive compounds. Characterization of CuO-NPs using FTIR, XRD, SEM, and EDX confirmed their purity, crystalline structure, and an average particle size of 74.

View Article and Find Full Text PDF

Ca/calmodulin-dependent protein kinase II (CaMKII) is one of hundreds of host-cell factors involved in the propagation of type A influenza virus (IAV), although its mechanism of action is unknown. Here, we identified CaMKII inhibitory peptide M3 by targeting its kinase domain using affinity-based screening of a tailored random peptide library. M3 inhibited IAV cytopathicity and propagation in cells by specifically inhibiting the acute-phase activation of retinoic acid-inducible gene I (RIG-I), which is uniquely regulated by CaMKII.

View Article and Find Full Text PDF

Severe fever with thrombocytopenia syndrome virus (SFTSV) is a human pathogen that is now endemic to several East Asian countries. The viral large (L) protein catalyzes viral transcription by stealing host mRNA caps via a process known as cap-snatching. Here, we establish an in vitro cap-snatching assay and present three high-quality electron cryo-microscopy (cryo-EM) structures of the SFTSV L protein in biologically relevant, transcription-specific states.

View Article and Find Full Text PDF

A jingmenvirus RNA-dependent RNA polymerase structurally resembles the flavivirus counterpart but with different features at the initiation phase.

Nucleic Acids Res

April 2024

Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, No. 262 Jin Long Street, Wuhan, Hubei 430207, China.

Jingmenviruses are a category of emerging segmented viruses that have garnered global attention in recent years, and are close relatives of the flaviviruses in the Flaviviridae family. One of their genome segments encodes NSP1 homologous to flavivirus NS5. NSP1 comprises both the methyltransferase (MTase) and RNA-dependent RNA polymerase (RdRP) modules playing essential roles in viral genome replication and capping.

View Article and Find Full Text PDF
Article Synopsis
  • - The respiratory syncytial virus (RSV) polymerase complex, made up of proteins L and P, is essential for RNA transcription and modification, but details on how inhibitors interact with it have been unclear.
  • - A new non-nucleoside inhibitor, JNJ-8003, demonstrates strong antiviral activity and effectively inhibits the polymerase complex, with structural analysis showing how it tightly binds to a specific site on the capping domain.
  • - JNJ-8003 disrupts early stages of RNA synthesis, revealing potential for developing broad-spectrum antiviral treatments based on its molecular interactions with the viral polymerase machinery.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!